The effect of Olanzapine on the prevention of radiotherapy-induced nausea and vomiting
Phase 3
Recruiting
- Conditions
- Radiotherapy induced nausea and vomiting.Nausea and vomiting
- Registration Number
- IRCT20170814035697N7
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Complete the consent form and announce cooperation
Age over 18 years
Radiotherapy for cancer (patients undergoing chemotherapy or surgery in addition to radiotherapy)
Radiotherapy for the first time
Exclusion Criteria
Patients with proven diabetes
Patients taking anti-lipid drugs
Patients taking antipsychotic drugs, including olanzapine
Pregnant women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The nausea and vomiting severity. Timepoint: The before, first, third and fifth days of radiotherapy. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method